Lonza entered into a definitive agreement for the sale of the Capsules & Health Ingredients (CHI) business to Lone Star Funds, at an enterprise value of CHF 2.3 billion (USD 3 billion). In connection with the deal
Tags :Daniel Blaettler
Lonza entered into a definitive agreement for the sale of the Capsules & Health Ingredients (CHI) business to Lone Star Funds, at an enterprise value of CHF 2.3 billion (USD 3 billion). In connection with the deal
